2022
DOI: 10.1016/j.ijmmb.2022.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of Mycoplasma pneumoniae in pediatric community–acquired lower respiratory tract infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
1
2
0
Order By: Relevance
“…9 Macrolides are widely used first-line medications for the treatment of M. pneumoniae, which is responsible for 40% of CAP worldwide and 30% of CAP in India. [10][11][12] Our investigation revealed that M. pneumoniae infection primarily occurs in children aged between 1-5 years, which was consistent with the previous reports. [13][14][15] Previous studies showed a significant difference in gender-based approaches, were girls being more susceptible to M. pneumoniae infection than boys.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…9 Macrolides are widely used first-line medications for the treatment of M. pneumoniae, which is responsible for 40% of CAP worldwide and 30% of CAP in India. [10][11][12] Our investigation revealed that M. pneumoniae infection primarily occurs in children aged between 1-5 years, which was consistent with the previous reports. [13][14][15] Previous studies showed a significant difference in gender-based approaches, were girls being more susceptible to M. pneumoniae infection than boys.…”
Section: Discussionsupporting
confidence: 91%
“…18,19 Macrolides are widely used as firstline medications for M. pneumoniae infection which accounts for 40% of CAP worldwide and 30% of CAP in India. [10][11][12] Although tetracyclines, fluoroquinolones and erythromycin are effective in treating M. pneumoniae infection, they are not recommended for use in children due to their toxicity. Until the rise of the drug resistance in 2000, macrolides were the potential antibiotic in treating pneumonia caused by M. pneumoniae.…”
Section: Discussionmentioning
confidence: 99%
“…[2,8,[16][17][18] For the child population, most studies have reported a higher positive rate for children aged > 5 years than for those < 5 years old [1,2,[18][19][20] ; the same result was observed in our study, which showed that children under the age of 6 years had the highest infection rate, which is thought to be related to incomplete immune mechanisms in this group and was easily infected by M pneumoniae. [5,21] Some studies have shown sex differences in M pneumoniae infections, [1,5,22,23] with some showing no differences. [16,18] In this study, no difference was observed; although the positive rates of females were higher than those of males in all 3 methods, the difference was not statistically significant.…”
Section: Discussionmentioning
confidence: 99%